Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Rare Kidney Cancer, Hereditary RCC

Ramaprasad Srinivasan

MD, PhD

🏢National Cancer Institute NIH🌐USA

Head Molecular Cancer Therapeutics Section

70
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Ramaprasad Srinivasan leads NCI trials in non clear cell and hereditary kidney cancer including papillary RCC and HLRCC. His work has defined molecular classifications and targeted therapy strategies for rare kidney cancer subtypes. He has led landmark studies of MET inhibitors in papillary RCC.

Share:

🧪Research Fields 研究领域

hereditary RCC
papillary RCC
HLRCC
MET inhibitors
translational oncology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Ramaprasad Srinivasan 的研究动态

Follow Ramaprasad Srinivasan's research updates

留下邮箱,当我们发布与 Ramaprasad Srinivasan(National Cancer Institute NIH)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment